{"id":921413,"title":"Archive 18: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age [2021-08-27] - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-01","captureTimestamp":"2026-03-01T17:48:35.119000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/mrna-adolescents.html","snippet":"Archive 18: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age [2021-08-27] Publication date: August 27, 2021 Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and publications…","rawSnapshotUrl":"/api/snapshots/raw/921413","browseUrl":"https://replay.healtharchive.ca/job-7/20260301174835/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/mrna-adolescents.html#ha_snapshot=921413","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}